Valeant's drug price hikes slammed by U.S. House Democrats

Valeant Pharmaceuticals shares plunged Monday on news that the Canadian company is in the crosshairs of U.S. legislators as a result of steep price hikes on two heart drugs its sells.

from CBC | Health News http://ift.tt/1VkVYl2